158 related articles for article (PubMed ID: 17109846)
1. Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy.
Rawls SM; Tallarida RJ; Zisk J
Eur J Pharmacol; 2006 Dec; 553(1-3):89-98. PubMed ID: 17109846
[TBL] [Abstract][Full Text] [Related]
2. Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception.
Aggarwal S; Shavalian B; Kim E; Rawls SM
Pharmacol Biochem Behav; 2009 Oct; 93(4):426-32. PubMed ID: 19538988
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.
Rawls SM; Cowan A; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):395-402. PubMed ID: 12235276
[TBL] [Abstract][Full Text] [Related]
4. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
Rawls SM; Cabassa J; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
[TBL] [Abstract][Full Text] [Related]
5. Involvement of α₂-adrenoceptors, imidazoline, and endothelin-A receptors in the effect of agmatine on morphine and oxycodone-induced hypothermia in mice.
Bhalla S; Andurkar SV; Gulati A
Fundam Clin Pharmacol; 2013 Oct; 27(5):498-509. PubMed ID: 22681550
[TBL] [Abstract][Full Text] [Related]
6. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
Rawls SM; Schroeder JA; Ding Z; Rodriguez T; Zaveri N
Neuropeptides; 2007 Aug; 41(4):239-47. PubMed ID: 17512052
[TBL] [Abstract][Full Text] [Related]
7. L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia.
Rawls SM; Tallarida RJ; Gray AM; Geller EB; Adler MW
J Pharmacol Exp Ther; 2004 Feb; 308(2):780-6. PubMed ID: 14610231
[TBL] [Abstract][Full Text] [Related]
8. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
9. GABAA receptors modulate cannabinoid-evoked hypothermia.
Rawls SM; Tallarida RJ; Kon DA; Geller EB; Adler MW
Pharmacol Biochem Behav; 2004 May; 78(1):83-91. PubMed ID: 15159137
[TBL] [Abstract][Full Text] [Related]
10. Agmatine blocks morphine-evoked hyperthermia in rats.
Rawls SM; Amin M; Zisk J
Brain Res; 2007 May; 1147():89-94. PubMed ID: 17376409
[TBL] [Abstract][Full Text] [Related]
11. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874.
Bhalla S; Rapolaviciute V; Gulati A
Eur J Pharmacol; 2011 Jan; 651(1-3):109-21. PubMed ID: 21114998
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.
Ding Z; Cowan A; Rawls SM
Brain Res; 2005 Dec; 1065(1-2):147-51. PubMed ID: 16309633
[TBL] [Abstract][Full Text] [Related]
14. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
Bereiter DA; Bereiter DF; Hirata H
Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy.
Ding Z; Cowan A; Tallarida R; Rawls SM
Neurosci Lett; 2006 Nov; 409(1):41-6. PubMed ID: 17018247
[TBL] [Abstract][Full Text] [Related]
16. Topical cannabinoid antinociception: synergy with spinal sites.
Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
[TBL] [Abstract][Full Text] [Related]
17. The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine- or WIN-55,212-2-induced analgesia and hypothermia in the guinea pig.
Maguma H; Taylor DA
Eur J Pharmacol; 2011 Jun; 660(2-3):334-40. PubMed ID: 21514292
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I₂ receptor ligands.
Li JX; Zhang Y; Winter JC
Eur J Pharmacol; 2011 Nov; 669(1-3):59-65. PubMed ID: 21867697
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid receptor agonist, WIN 55,212-2, inhibits cool-specific lamina I medullary dorsal horn neurons.
Ogawa A; Meng ID
Neuroscience; 2006 Nov; 143(1):265-72. PubMed ID: 16949215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
